SynthesisBMC cardiovascular disorders2026
Prevalence and associated factors of hypertension among adults in Sub-Saharan Africa: a systematic review and meta-analysis of community-based studies.
Synthesis in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hypertension Among Medical Students in Lubumbashi, Democratic Republic of the Congo: Prevalence, Associated Factors and Comparison of the 2025 ACC/AHA and JNC 7 Classifications.International journal of hypertension · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHypertension (HT) is a major global public health challenge, responsible for more than 10 million deaths annually. In sub-Saharan Africa (SSA), its prevalence is high and rising, driven by rapid urbanisation, nutritional transition, and increasing sedentary behaviour, while screening and control rates remain suboptimal. This systematic review and meta-analysis aimed to estimate the prevalence of HT among adults in SSA and identify its key associated factors.
methodsThe protocol was registered in PROSPERO (CRD420251021429) and conducted in accordance with PRISMA 2020. We included cross-sectional studies published between January 2010 and November 2025, involving adults (≥ 18 years) and defining HT according to JNC7. Searches were conducted across seven databases and grey literature. Methodological quality was assessed using Joanna Briggs Institute tools (threshold ≥ 50%). A random-effects meta-analysis was performed using Stata 16.
resultsOf 11,895 records screened, 52 studies were included. The pooled prevalence of HT was 27.09% (95% CI: 24.22%–29.96%; I² = 99.5%). Regional estimates ranged from 22.43% in Southern Africa to 32.75% in Central Africa. Major factors associated with HT included age > 50 years, which conferred nearly a fivefold increased risk (OR = 4.93; 95% CI: 3.61–6.72), male sex (OR = 1.80; 95% CI: 1.14–2.84), diabetes mellitus (OR = 4.01; 95% CI: 2.88–5.58), abdominal obesity (OR = 2.86; 95% CI: 2.33–3.52), overweight/obesity (OR = 2.72; 95% CI: 2.26–3.28), alcohol consumption (OR = 1.97; 95% CI: 1.57–2.46), smoking (OR = 1.69; 95% CI: 1.44–1.97), physical inactivity (OR = 1.60; 95% CI: 1.36–1.89), low fruit and vegetable intake (OR = 1.42; 95% CI: 1.16–1.75), urban residence (OR = 1.21; 95% CI: 1.08–1.35), and a family history of HT (OR = 2.37; 95% CI: 1.66–3.38). Occupational status was not significantly associated with HT (OR = 1.21; 95% CI: 0.76–1.93).
conclusionMore than one in four adults in SSA is hypertensive, with substantial regional disparities. Most identified determinants are modifiable, underscoring the urgent need for strengthened primary prevention through healthier lifestyles, community-based screening, and integrated management of metabolic disorders. Context-specific strategies are essential to curb this silent epidemic and reduce the cardiovascular burden across the region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.